Intersect ENT Reports Second Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/6/2026
- Dow closes at record on Mideast optimism; SpaceX, AMD drag Nasdaq
- SpaceX tumbles amid AI spending concerns; Musk outlines $1 trillion revenue target
- AMD shares slide 8% after Musk flags plans to buy Nvidia chips for SpaceX
- AZN spikes 6% after report it denies AstraZeneca-BMS merger talks
- New report warns China transceiver ban would hurt U.S. AI giants
- Salesforce president Srini Tallapragada steps down, becomes advisor
- Sandisk (SNDK) Tops Q4 EPS by $4.66, Offers Guidance
- EverCommerce names Alex Goor as new CEO, founder steps down
- AMD shares slide 8% after Musk flags plans to buy Nvidia chips for SpaceX
- Crude Inventory Rose 2.5 Million Barrels Last Week - EIA
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
- After-Hours Movers: SPCX, AMD, ANET, PINS, APPS, UPST, ZETA, BKNG, LCID, CPNG, MTCH
- After-Hours Stock Movers: PLTR, SNAP, ON, ICHR, WGS, WHR
- After-Hours Stock Movers: AAPL, AMZN, COIN, RBLX, RDDT, AXTI, FND, WU, GDDY
- After-Hours Stock Movers: META, MSFT, CMG, SBUX, CVNA, LRCX, FTNT, QCOM, TDOC
Intersect ENT (XENT) Misses Q2 EPS by 9c, Revenues Beat
August 4, 2020 7:23 AM EDTIntersect ENT (NASDAQ: XENT) reported Q2 EPS of ($0.65), $0.09 worse than the analyst estimate of ($0.56). Revenue for the quarter came in at $9.8 million versus the consensus estimate of $5.41 million.
Second Quarter 2020 Overview
Revenue of $9.8 million in the second quarter of 2020, compared to $26.7 million in the second quarter of 2019Strong sales trend reinforces confidence in sequential second half revenue growthCash, Cash Equivalents and Short-term Investments of $135.8 million"While well below last year, we achieved... More
